Table of Contents

CommentaryP:54-56

Perspective on molecular cancer
Oliver Swinton*

DOI: : 10.37532/pulcmr-.2022.4(3).53-55

• Abstract
• Full-Text
• PDF

Short communicationP:48-50

Endocrine therapy on type II Diabetes in breast cancer
Joseph Dore*

DOI: 10.37532/pulcmr-.2022.4(3).48-50

• Abstract
• Full-Text
• PDF

ReviewP:51-53

Malignancies chemotherapy apoptosis
George Smith*

DOI: 10.37532/pulcmr-.2022.4(3).51-53

• Abstract
• Full-Text
• PDF

PerspectiveP:59-60

Gastric pulmonary resection cancer
Sophia*

DOI: 10.37532/pulcmr-.2022.4(3).59-60

• Abstract
• Full-Text
• PDF

ReviewP:56-58

Basal cell carcinoma pathogenesis
Jacob Hilary*

DOI: 10.37532/pulcmr-.2022.4(3).56-58.

• Abstract
• Full-Text
• PDF

OpinionP:66-67

Gemcitabine Improves Survival and Clinical Benefits for Patients with Advanced Pancreatic Cancer
Charles Darwin*

DOI: 10.37532/pulcmr-.2022.4(5).66-67

• Abstract
• Full-Text
• PDF